Beneficial Insectary Inc. is North America's largest independent producer of beneficial insects and mites.
Two products were approved by the Welfare Scheme - Velactis and Ketofen.
To carry out these projects, Seqens relies on the SEQENS’Lab, its R&D center, and on four of its APIs and pharmaceutical intermediates production...
Gvoke® net sales grew 370% quarter over quarter to $9.4 million driven by launch of Gvoke HypoPen®.
This Agreement will enable a combination of the know-how in preclinical testing developed by ProDigest and the expertise in clinical trials and...
KEEPMED has designed and developed keePAP® - a unique, responsive and personalized positive airway pressure (PAP) device for the treatment of...
This €8 million innovative project confirms Ceva’s commitment to improving preventative animal health and reducing the use of antibiotics. The...
The site was inaugurated in the presence of Emmanuel Macron, President of the French Republic and Bruno Lemaire, Minister of the Economy, Finance and...
Gvoke® net sales were $2.0 million in Q2 2020. Gvoke PFS prescriptions grew 72% quarter over quarter. July availability of Gvoke HypoPen™ accelerates...
VantAI and TARA Biosystems today announced the launch of a biology-driven, AI-enabled collaboration. The partnership will leverage TARA’s state-of-the...
